Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 127 Records) |
| Query Trace: Neoplasms and VHL[original query] |
|---|
| Investigating the role of somatic sequencing platforms for phaeochromocytoma and paraganglioma in a large UK cohort. Clinical endocrinology 2021 12 97 (4): 448-459. Winzeler Bettina, Tufton Nicola, S Lim Eugenie, Challis Ben G, Park Soo-Mi, Izatt Louise, Carroll Paul V, Velusamy Anand, Hulse Tony, Whitelaw Benjamin C, Martin Ezequiel, Rodger Fay, Maranian Melanie, Clark Graeme R, A Akker Scott, Maher Eamonn R, Casey Ruth |
| Characterization of Genetic Heterogeneity in Recurrent Metastases of Renal Cell Carcinoma. Cancers 2021 12 13 (24): . Sauter-Meyerhoff Carolin, Bohnert Regina, Mazzola Pascale, Stühler Viktoria, Kandabarau Siarhei, Büttner Florian A, Winter Stefan, Herrmann Lisa, Rausch Steffen, Hennenlotter Jörg, Fend Falko, Scharpf Marcus, Stenzl Arnulf, Ossowski Stephan, Bedke Jens, Schwab Matthias, Schaeffeler El |
| Germline Mutation Landscape and Associated Clinical Characteristics in Chinese Patients With Renal Cell Carcinoma. Frontiers in oncology 2021 12 11 737547. Kong Wen, Yang Tongtong, Wen Xiaodong, Mu Zhongyi, Zhao Cheng, Han Sujun, Tian Jing, Zhang Xinhao, Zhou Tao, Zhang Yanrui, Lou Feng, Cao Shanbo, Wang Huina, Zhang J |
| Hereditary Leiomyomatosis and Renal Cell Cancer-Recognizing Patterns May Save Lives. Journal of kidney cancer and VHL 2022 9 9 (2): 27-31. Catarina Tavares, Quental Maria Sofia, Brandão José Ricardo, Silva-Ramos Migu |
| Pancancer analysis of a potential gene mutation model in the prediction of immunotherapy outcomes. Frontiers in genetics 2022 9 13 917118. Yu Lishan, Gong Caife |
| Hypoxia-inducible factor underlies von Hippel-Lindau disease stigmata. eLife 2022 8 11 . Ohh Michael, Taber Cassandra C, Ferens Fraser G, Tarade Dani |
| Differences in actionable genomic alterations between brain metastases and non?brain metastases in patients with non?small cell lung cancer. International journal of oncology 2022 Sep 61 (3): . Nian Rui, Jiang Huihui, Zhao Jiangman, Hou Wanle, Zhang Hua, Ma Jiangtao, Lv Pengbiao, Jiang Lisha, Wang Yongpan, Xu Yue, Wu Shouxin, Lou Jingwei, Li Wanj |
| Co-occurrence of VHL and SDHA Pathogenic Variants: A Case Report. Frontiers in oncology 2022 7 12 925582. Tung Moon Ley, Chandra Bharatendu, Dillahunt Kyle, Gosse Matthew D, Sato T Shawn, Sidhu Al |
| VHL Ser65 mutations enhance HIF2? signaling and promote epithelial-mesenchymal transition of renal cancer cells. Cell & bioscience 2022 5 12 (1): 52. Ma Xueyou, Tan Zenglai, Zhang Qin, Ma Kaifang, Xiao Jun, Wang Xiong, Wang Yanan, Zhong Mengjie, Wang Yu, Li Jing, Zeng Xing, Guan Wei, Wang Shaogang, Gong Kan, Wei Gong-Hong, Wang Zhih |
| Comparative analysis of cancer gene mutations using targeted sequencing in matched primary and recurrent gastric cancers after chemotherapy. Genes & genomics 2022 May . Huh Yeon-Ju, Cho Sung-Yup, Cho Min-Sun, Lee Kyoung-Eun, Lee Joo- |
| Germline Mutations Related to Primary Hyperparathyroidism Identified by Next-Generation Sequencing. Frontiers in endocrinology 2022 5 13 853171. Park Hye-Sun, Lee Yeon Hee, Hong Namki, Won Dongju, Rhee Yum |
| Differential VHL Mutation Patterns in Bilateral Clear Cell RCC Distinguishes Between Independent Primary Tumors and Contralateral Metastatic Disease. Urology 2022 4 165 170-177. Vocke Cathy D, Ricketts Christopher J, Metwalli Adam R, Pinto Peter A, Gautam Rabindra, Raffeld Mark, Merino Maria J, Ball Mark W, Linehan W Marst |
| Evaluation of a seven gene mutational profile as a prognostic factor in a population-based study of clear cell renal cell carcinoma. Scientific reports 2022 4 12 (1): 6478. van de Pol Jeroen A A, Ferronika Paranita, Westers Helga, van Engeland Manon, Terpstra Martijn M, Smits Kim M, de Lange Kim, van den Brandt Piet A, Sijmons Rolf H, Schouten Leo J, Kok Kla |
| Early dynamics of circulating tumor DNA predict clinical response to immune checkpoint inhibitors in metastatic renal cell carcinoma. International journal of urology : official journal of the Japanese Urological Association 2022 2 29 (5): 462-469. Koh Yoko, Nakano Kosuke, Katayama Kotoe, Yamamichi Gaku, Yumiba Satoru, Tomiyama Eisuke, Matsushita Makoto, Hayashi Yujiro, Yamamoto Yoshiyuki, Kato Taigo, Hatano Koji, Kawashima Atsunari, Ujike Takeshi, Imamura Ryoichi, Yamaguchi Rui, Imoto Seiya, Shiotsu Yukimasa, Nonomura Norio, Uemura Motohi |
| The germline mutational landscape of genitourinary cancers and its indication for prognosis and risk. BMC urology 2022 11 22 (1): 196. Yang Yong, Zhang Guoying, Hu Chen, Luo Wei, Jiang Haiyang, Liu Shaoyou, Yang Ho |
| The prevalence of germline pathogenic variants in Estonian colorectal cancer patients: results from routine clinical setting 2016-2021. Frontiers in genetics 2022 11 13 1020543. Roht Laura, Tooming Mikk, Rekker Kadri, Roomere Hanno, Toome Kadri, Murumets Ülle, Šamarina Ustina, Õunap Katrin, Kahre Tii |
| T and NK cell abundance defines two distinct subgroups of renal cell carcinoma. Oncoimmunology 2022 1 11 (1): 1993042. Lee Moon Hee, Järvinen Petrus, Nísen Harry, Brück Oscar, Ilander Mette, Uski Ilona, Theodoropoulos Jason, Kankainen Matti, Mirtti Tuomas, Mustjoki Satu, Kreutzman An |
| Hereditary Renal Cell Carcinoma: Is Age an Independent Criterion for Genetic Testing? A Large Cohort from a Latin America Referral Center. Journal of kidney cancer and VHL 2023 8 10 (3): 17-22. Tomás Carminatti, Patricio Aitor García Marchiñena, Ignacio Pablo Tobia González, Valeria de Miguel, Marcelo Martín Serra, Pablo Germán Kalfayan, Alberto Manuel Jura |
| Cerebrospinal fluid as a liquid biopsy for molecular characterization of brain metastasis in patients with non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2023 7 182 107292. Georgios Tsakonas, Vasisht Tadigotla, Sudipto K Chakrabortty, Giuseppe Stragliotto, Dalin Chan, Rolf Lewensohn, Wei Yu, Johan K Skog, Per Hydbring, Simon Ekm |
| Potential Role of VHL, PTEN, and BAP1 Mutations in Renal Tumors. Journal of clinical medicine 2023 7 12 (13): . Krisztián Szegedi, Zsuzsanna Szabó, Judit Kállai, József Király, Erzsébet Szabó, Zsuzsanna Bereczky, Éva Juhász, Balázs Dezs?, Csaba Szász, Barbara Zsebik, Tibor Flaskó, Gábor Halm |
| Genomic profiles of renal cell carcinoma in a small Chinese cohort. Frontiers in oncology 2023 7 13 1095775. Sheng Tai, Dan-Dan Xu, Zhixian Yu, Yu Guan, Shuiping Yin, Jun Xiao, Song Xue, Chaozhao Lia |
| Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2?+?metastatic breast cancer. Scientific reports 2023 6 13 (1): 9928. Kyoungmin Lee, Jongwon Lee, Jungmin Choi, Sung Hoon Sim, Jeong Eun Kim, Min Hwan Kim, Yeon Hee Park, Jee Hyun Kim, Su-Jin Koh, Kyong Hwa Park, Myoung Joo Kang, Mi Sun Ahn, Kyoung Eun Lee, Hee-Jun Kim, Hee Kyung Ahn, Han Jo Kim, Keon Uk Park, In Hae Pa |
| Genetic mutations in HER2-positive breast cancer: possible association with response to trastuzumab therapy. Human genomics 2023 5 17 (1): 43. Nermine H Zakaria, Doaa Hashad, Marwa H Saied, Neamat Hegazy, Alyaa Elkayal, Eman Tay |
| Clear cell renal cell carcinoma molecular variations in non-Hispanic White and Hispanic patients. Cancer medicine 2023 4 . Ken Batai, Yuliang Chen, Brenna A Rheinheimer, Amit Arora, Ritu Pandey, Ronald L Heimark, Erika R Bracamonte, Nathan A Ellis, Benjamin R L |
| Prevalence of germline mutations in cancer susceptibility genes in Chinese patients with renal cell carcinoma. Translational andrology and urology 2023 3 12 (2): 308-319. Feng Huayi, Cao Shouqing, Ouyang Qing, Li Huaikang, Li Xiubin, Chen Ke, Zhang Xiangyi, Huang Yan, Zhang Xu, Ma X |
| Two Single Nucleotide Polymorphisms in the Von Hippel-Lindau Tumor Suppressor Gene in Patients with Clear Cell Renal Cell Carcinoma. International journal of molecular sciences 2023 2 24 (4): . Chraba?ska Magdalena, Szweda-Gandor Nikola, Drozdzowska Bog |
| Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 2 OF1-OF12. Vasudev Naveen S, Scelo Ghislaine, Glennon Kate I, Wilson Michelle, Letourneau Louis, Eveleigh Robert, Nourbehesht Nazanin, Arseneault Madeleine, Paccard Antoine, Egevad Lars, Viksna Juris, Celms Edgars, Jackson Sharon M, Abedi-Ardekani Behnoush, Warren Anne Y, Selby Peter J, Trainor Sebastian, Kimuli Michael, Cartledge Jon, Soomro Naeem, Adeyoju Adebanji, Patel Poulam M, Wozniak Magdalena B, Holcatova Ivana, Brisuda Antonin, Janout Vladimir, Chanudet Estelle, Zaridze David, Moukeria Anush, Shangina Oxana, Foretova Lenka, Navratilova Marie, Mates Dana, Jinga Viorel, Bogdanovic Ljiljana, Kovacevic Bozidar, Cambon-Thomsen Anne, Bourque Guillaume, Brazma Alvis, Tost Jörg, Brennan Paul, Lathrop Mark, Riazalhosseini Yasser, Banks Rosamonde |
| Integrative Analysis of Germline Rare Variants in Clear and Non-Clear Cell Renal Cell Carcinoma. medRxiv : the preprint server for health sciences 2023 1 . Han Seunghun, Camp Sabrina Y, Chu Hoyin, Collins Ryan, Gillani Riaz, Park Jihye, Bakouny Ziad, Ricker Cora A, Reardon Brendan, Moore Nicholas, Kofman Eric, Labaki Chris, Braun David, Choueiri Toni K, AlDubayan Saud H, Van Allen Eliezer |
| SDHB exon 1 deletion: A recurrent germline mutation in Colombian patients with pheochromocytomas and paragangliomas. Frontiers in genetics 2023 1 13 999329. Manotas María Carolina, Rivera Ana Lucía, Gómez Ana Milena, Abisambra Patricia, Guevara Gonzalo, Medina Vilma, Tapiero Sandra, Huertas Antonio, Riaño-Moreno Julián, Mejía Juan Carlos, Gonzalez-Clavijo Angélica María, Tapiero-García Mireya, Cuéllar-Cuéllar Andrés Arturo, Fierro-Maya Luis Felipe, Sanabria-Salas María Caroli |
| Frequency of Pathogenic Germline Mutations in Early and Late Onset Familial Breast Cancer Patients Using Multi-Gene Panel Sequencing: An Egyptian Study. Genes 2023 1 14 (1): . Nassar Auhood, Zekri Abdel-Rahman N, Kamel Mahmoud M, Elberry Mostafa H, Lotfy Mai M, Seadawy Mohamed G, Hassan Zeinab K, Soliman Hany K, Lymona Ahmed M, Youssef Amira Salah El-D |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 01, 2023
- Content source: